Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience

E Szczepanek, O Chukwu, M Kamińska… - Leukemia & …, 2022 - Taylor & Francis
We report on long-term outcomes of 267 patients (pts) with chronic myeloid leukemia (CML)
treated with imatinib administered as initial therapy. The median follow-up time was 11.4 …
被引用次数：3 相关文章

[引用][C] Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience

E Szczepanek, O Chukwu, M Kamińska, H Wysogląd… - 2022 - ruj.uj.edu.pl

Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience

E Szczepanek, O Chukwu… - Leukemia & …, 2022 - pubmed.ncbi.nlm.nih.gov
We report on long-term outcomes of 267 patients (pts) with chronic myeloid leukemia (CML)
treated with imatinib administered as initial therapy. The median follow-up time was 11.4 …

Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience.

E Szczepanek, O Chukwu, M Kamińska… - Leukemia & …, 2022 - europepmc.org
We report on long-term outcomes of 267 patients (pts) with chronic myeloid leukemia (CML)
treated with imatinib administered as initial therapy. The median follow-up time was 11.4 …

[引用][C] Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience

E Szczepanek, O Chukwu, M Kamińska… - Leukemia and …, 2022 - ruj.uj.edu.pl
Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with
imatinib : a 20-year single-centre experience Przejdź do treści Pomoc A A A Zmień kontrast …